{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T21:13:55Z","timestamp":1769116435991,"version":"3.49.0"},"reference-count":36,"publisher":"BMJ","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Clin Pathol"],"accepted":{"date-parts":[[2009,5,9]]},"published-print":{"date-parts":[[2009,10]]},"abstract":"<jats:p>\u03b1<jats:sub>1<\/jats:sub>-Antitrypsin (AAT), a 52 kDa plasma protein, is produced mainly in the liver. It is the most abundant circulating <jats:underline>ser<\/jats:underline>ine <jats:underline>p<\/jats:underline>roteinase <jats:underline>in<\/jats:underline>hibitor (serpin). It has also previously been called protease inhibitor to reflect its function as a general inhibitor of serine proteases. Its main physiological role is to inhibit neutrophil elastase and it contributes to the innate immune system as an anti-inflammatory protein. Severe AAT deficiency is most prevalent in northern Europeans affecting about 1 in 3000 of the population. AAT deficiency predisposes individuals who smoke to developing pulmonary emphysema in the fourth\u2013fifth decade of adult life and to childhood cirrhosis in about 10% of cases, with the initial presentation being prolonged neonatal jaundice. The mean interval from presentation with symptoms to diagnosis in adults is about 8 years. The condition is under-recognised and under-diagnosed. The only effective current treatment for the severe liver disease that occurs in childhood currently is liver transplantation. Replacement therapy with purified AAT from human plasma is being used in clinical practice for the lung disease though it is not known whether this influences the outcome of this chronic condition. The liver pathology arises from intracellular polymerisation of mutant protein, and attenuation of polymerisation is a potential target for therapy.<\/jats:p>","DOI":"10.1136\/jcp.2008.063495","type":"journal-article","created":{"date-parts":[[2009,9,25]],"date-time":"2009-09-25T15:37:06Z","timestamp":1253893026000},"page":"865-869","source":"Crossref","is-referenced-by-count":30,"title":["\u03b1<sub>1<\/sub>-Antitrypsin deficiency: best clinical practice"],"prefix":"10.1136","volume":"62","author":[{"given":"N A","family":"Kalsheker","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2009,9,25]]},"reference":[{"key":"2025092612273287000_62.10.865.1","doi-asserted-by":"publisher","DOI":"10.3109\/00365516309051324"},{"key":"2025092612273287000_62.10.865.2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1843.1997.tb00060.x"},{"key":"2025092612273287000_62.10.865.3","doi-asserted-by":"publisher","DOI":"10.1172\/JCI11791"},{"key":"2025092612273287000_62.10.865.4","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)66781-5"},{"key":"2025092612273287000_62.10.865.5","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-111-12-982"},{"key":"2025092612273287000_62.10.865.6","doi-asserted-by":"publisher","DOI":"10.1038\/nsb1196-910"},{"key":"2025092612273287000_62.10.865.7","first-page":"205","article-title":"Alpha1-antitrypsin deficiency panniculitis.","volume":"71","author":"McBean","year":"2003","journal-title":"Cutis"},{"key":"2025092612273287000_62.10.865.8","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/89.11.877-a"},{"key":"2025092612273287000_62.10.865.9","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.35.1.6"},{"key":"2025092612273287000_62.10.865.10","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/S0140-6736(75)90728-X","article-title":"Chronic pancreatitis and alpha1-antitrypsin deficiency.","volume":"2","author":"Novis","year":"1975","journal-title":"Lancet"},{"key":"2025092612273287000_62.10.865.11","doi-asserted-by":"publisher","DOI":"10.1165\/rcmb.2007-0107OC"},{"key":"2025092612273287000_62.10.865.12","doi-asserted-by":"publisher","DOI":"10.1186\/1465-9921-9-52"},{"key":"2025092612273287000_62.10.865.13","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2008.095497"},{"key":"2025092612273287000_62.10.865.14","doi-asserted-by":"publisher","DOI":"10.1378\/chest.08-1129"},{"key":"2025092612273287000_62.10.865.15","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21979"},{"key":"2025092612273287000_62.10.865.16","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-0004.2003.00143.x"},{"key":"2025092612273287000_62.10.865.17","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/j.0954-6820.1978.tb08452.x","article-title":"Natural history and life expectancy in severe alpha1-antitrypsin deficiency Pi Z.","volume":"204","author":"Larsson","year":"1978","journal-title":"Acta Med Scand"},{"key":"2025092612273287000_62.10.865.18","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/0007-0971(83)90002-5","article-title":"Alpha1-antitrypsin deficiency: the clinical and physiological features of pulmonary emphysema subjects homozygous for Pi type Z.","volume":"77","author":"Tobin","year":"1983","journal-title":"Br J Dis Chest"},{"key":"2025092612273287000_62.10.865.19","doi-asserted-by":"publisher","DOI":"10.1378\/chest.128.3.1179"},{"key":"2025092612273287000_62.10.865.20","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2007.02.024"},{"key":"2025092612273287000_62.10.865.21","doi-asserted-by":"publisher","DOI":"10.3949\/ccjm.61.6.461"},{"key":"2025092612273287000_62.10.865.22","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1056\/NEJM198001313020505","article-title":"Liver transplantation for advance liver disease with alpha1-antitrypsin deficiency.","volume":"302","author":"Hood","year":"1990","journal-title":"New Engl J Med"},{"key":"2025092612273287000_62.10.865.23","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(00)80103-8"},{"key":"2025092612273287000_62.10.865.24","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.0954-6820.1974.tb08170.x","article-title":"Cirrhosis and malignant hepatoma in \u03b11-antitrypsin deficiency.","volume":"193","author":"Eriksson","year":"1974","journal-title":"Acta Med Scand"},{"key":"2025092612273287000_62.10.865.25","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840010611"},{"key":"2025092612273287000_62.10.865.26","doi-asserted-by":"publisher","DOI":"10.1165\/rcmb.F250"},{"key":"2025092612273287000_62.10.865.27","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.0208145"},{"key":"2025092612273287000_62.10.865.28","doi-asserted-by":"publisher","DOI":"10.2337\/db06-1273"},{"key":"2025092612273287000_62.10.865.29","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.20494"},{"key":"2025092612273287000_62.10.865.30","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1373\/clinchem.2007.102798","article-title":"SERPINA1 gene variants in individuals from the general population with reduced \u03b11-antitrypsin concentrations.","volume":"5","author":"Zorzetto","year":"2008","journal-title":"Clin Chem"},{"key":"2025092612273287000_62.10.865.31","doi-asserted-by":"publisher","DOI":"10.1378\/chest.100.3.703"},{"key":"2025092612273287000_62.10.865.32","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1517\/14712598.8.4.515","article-title":"Augmentation therapy in alpha1-antitrypsin deficiency.","volume":"4","author":"Heresi","year":"2008","journal-title":"Expert Opin Biol Ther"},{"key":"2025092612273287000_62.10.865.33","doi-asserted-by":"crossref","first-page":"192","DOI":"10.4414\/smw.2008.11991","article-title":"Alpha1-antitrypsin: now available but do we need it?","volume":"138","author":"Russi","year":"2008","journal-title":"Swiss Med Wkly"},{"key":"2025092612273287000_62.10.865.34","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)66781-5"},{"key":"2025092612273287000_62.10.865.35","doi-asserted-by":"crossref","unstructured":"Brand P Schulte M Wencker M . Lung deposition of inhaled alpha1-proteinase inhibitor in CF and alpha1-antitrypsin deficiency. Eur Respir J. Published online: 27 February 2009. doi:10.1183\/09031936.00118408","DOI":"10.1183\/09031936.00118408"},{"key":"2025092612273287000_62.10.865.36","doi-asserted-by":"publisher","DOI":"10.1021\/jm070687z"}],"container-title":["Journal of Clinical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jcp.2008.063495","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T19:27:39Z","timestamp":1758914859000},"score":1,"resource":{"primary":{"URL":"https:\/\/jcp.bmj.com\/lookup\/doi\/10.1136\/jcp.2008.063495"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9,25]]},"references-count":36,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2009,9,25]]},"published-print":{"date-parts":[[2009,10]]}},"alternative-id":["10.1136\/jcp.2008.063495"],"URL":"https:\/\/doi.org\/10.1136\/jcp.2008.063495","relation":{},"ISSN":["0021-9746","1472-4146"],"issn-type":[{"value":"0021-9746","type":"print"},{"value":"1472-4146","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,9,25]]}}}